Evidence map›Paper›PMID 41658223›Full record

ArticleBMJ public health2026

Prevalence of gallstone disease in India: insights from a community-based cross-sectional study.

Shravani Umesh Mohite, Nandkumar Panse, Ravi Kannan, Ritesh Tapkire, Satyajeet Pradhan, Ashish Gulia, Kiran Mirgane, Suhas Dhalgade, Venkatesh Sangale, Sanjay Khandagale and 21 more

Abstract read
In one paragraph

Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Shravani Umesh MohiteDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Nandkumar PanseNargis Dutt Memorial Cancer Hospital, Barshi, India.
Ravi KannanDepartment of Oncology, Cachar Cancer Hospital and Research Centre, Silchar, India.
Ritesh TapkireCachar Cancer Hospital and Research Center, NS Avenue, Silchar, India.
Satyajeet PradhanDepartment of Radiation Oncology and Homi Bhabha Cancer Center, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi, India.
Ashish GuliaDepartment of Surgical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Chandigarh, India.
Kiran MirganeNargis Dutt Memorial Cancer Hospital, Barshi, India.
Suhas DhalgadeNargis Dutt Memorial Cancer Hospital, Barshi, India.
Venkatesh SangaleNargis Dutt Memorial Cancer Hospital, Barshi, India.
Sanjay KhandagaleNargis Dutt Memorial Cancer Hospital, Barshi, India.
Abdul Kadir LaskarDepartment of Oncology, Cachar Cancer Hospital and Research Centre, Silchar, India.
Ujjala DasDepartment of Oncology, Cachar Cancer Hospital and Research Centre, Silchar, India.
Jyotish DuttaDepartment of Oncology, Cachar Cancer Hospital and Research Centre, Silchar, India.
Tirthankar ChakrabortyDepartment of Oncology, Cachar Cancer Hospital and Research Centre, Silchar, India.
Ruchi PathakDepartment of Epidemiology and Community Screening, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi, India.
Manigreeva KrishnatreyaDr. B. Borooah Cancer Institute, Guwahati, India.ORCID https://orcid.org/0000-0002-9247-4814
Vandita PahwaDepartment of Preventive Oncology, Homi Bhabha Cancer Hospital and Research Centre, Chandigarh, India.
Lekha KotkarDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Ankita ManjrekarDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Kamlesh KadamDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Grace Sarah GeorgeDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Romi MoirangthemDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Kaizar BharmalDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Pravin DoibaleDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.ORCID https://orcid.org/0009-0004-2767-0116
Vikas OstwalDepartment of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Shailesh V ShrikhandeDepartment of Gastrointestinal and HPB Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Suyash KulkarniDepartment of Radiology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Nitin ShettyDepartment of Radiodiagnosis and Interventional Radiology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Mumbai, India.
Rajesh DikshitDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.
Pankaj ChaturvediHomi Bhabha National Institute (HBNI), Mumbai, India.
Sharayu MhatreDivision of Molecular Epidemiology and Population Genomics, Center for Cancer Epidemiology, Navi Mumbai, India.ORCID https://orcid.org/0000-0001-7072-802X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gallstone disease (GSD) is a prevalent gastrointestinal condition with known associations to gallbladder cancer (GBC). India exhibits heterogeneity in GSD burden across different geographic regions. However, limited data are available from high and low-risk regions. Methods: A community-based cross-sectional study was conducted across high-risk (Kamprup (Guwahati), Silchar, Mullanpur, Varanasi) and low-risk (Barshi) GBC regions using structured interviews. Self-reported history of gallstones was collected through interviewing participants from two sources, the Gallstone Survey (GS) and the 0.5 Million Indian Women Screening study. Per cent prevalence was estimated for GSD and stratified analysis based on sex, age and region was conducted. We estimated the population attributable fraction (PAF) for GSD in high and low risk GBC regions. Results: A total of 28 395 participants (9158 males, 19 237 females) aged 30-65 years were enrolled. Gallstone prevalence was highest in Mullanpur (10.8%, 95% CI 8.4% to 13.5%) and Kamprup (Guwahati) (10.7%, 95% CI (7.7% to 14.4%) and lowest in Barshi (0.3%, 95% CI 0.3% to 0.4%). Age and gender stratified analysis showed increasing gallstone prevalence with age among females in high-risk GBC regions, and no age-linked trends in GSD prevalence were observed in low-risk regions for both genders. The estimated overall PAF for high risk GBC regions was 2.7%, whereas in the low-risk region of Barshi the overall PAF was 0.2%. Conclusion: Significant regional and sex-based variation in GSD prevalence across India aligns with high-risk zones for GBC, underscoring the need for targeted surveillance and aetiologic research.

Indexed as

Community-Based Participatory ResearchCross-Sectional StudiesData CollectionEpidemiologyPrevalence

Identifiers

PMID41658223
PMCPMC12878284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.